Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Snowsill T, Huxley N, Hoyle M, et al. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. Southampton (UK): NIHR Journals Library; 2014 Sep. (Health Technology Assessment, No. 18.58.)
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Show detailsDr Ian Frayling MA PhD FRCPath FEBLM, Consultant in Genetic Pathology and Laboratory Director, All Wales Medical Genetics Service
Description of data
Anonymised data were provided by Ian Frayling from the All Wales Medical Genetics Service, including details of predictive tests within 33 families with LS mutations. For each predictive test we were provided with the date when the family mutation was first reported, the date when the predictive test result was reported, the sex of the person receiving the predictive test and whether or not they were diagnosed as a LS carrier. In some cases the data also contained the kinship of the predictive test, i.e. whether the person was a FDR, SDR or more distant relation of the index case.
The data cover reports from October 2000 to November 2012 and include details of 109 predictive tests on members of 33 families. The mean time between diagnostic test and predictive test was 747 days (median 415 days, interquartile range 182–1206 days, range 0–3510 days).
Proportion of relatives who test positive
Of the 109 relatives who received predictive testing, 44 (40%, 95% CI 31% to 50%) tested positive for the family mutation. There is significant evidence to suggest that the true proportion who would test positive is < 0.5 (one-tailed binomial test, p = 0.027), and there are a number of factors which contribute to this, including non-paternity, de novo mutations, mortality bias and offering testing to those at < 50% genetic risk because it is not possible (e.g. owing to death or to testing being declined) or not appropriate to test intervening relatives.
Proportion of relatives who are male
Of the 109 relatives who received predictive testing, 39 (36%, 95% CI 27% to 46%) were male. There is significant evidence to suggest that the true proportion who would be male is not 0.5 (two-tailed binomial test, p = 0.004). Ian Frayling also analysed the sex of the index cases (those receiving diagnostic tests) and found that there were 17 female and 16 male index cases. It is his belief that men are less likely to take up predictive testing than women and we cannot identify any alternative explanations.
Independence of test result and sex
We tested whether or not the test result and sex of the relative were dependent variables by constructing a 2 × 2 table (Table 126) and using a Pearson’s chi-squared test. We found no evidence of dependency (chi-squared = 0.262, degrees of freedom = 1, p = 0.61).
Kinship of relatives to proband
For 70 (64%) of the 109 tests, we were provided with the kinship of the relative being tested to the proband. These are summarised in Table 127, which shows that 47% of relatives tested are FDRs while 53% are more distantly related.
Expected number of relatives tested per proband over time
The data provided clearly indicated that relatives are not tested immediately after a positive diagnostic test. It is important to know the expected number of relatives that would be tested for each proband over time as this has an effect on workload and the overall effectiveness of testing (if all relatives waited decades before being tested for the family mutation, most of the potential benefit of testing would have been forgone).
We analysed the number of relatives tested per proband by using a Kaplan–Meier-style estimator. We assumed that all families were censored at the date of the most recent database search (an effective ‘study end’ date of 1 November 2012).
If di is the number of predictive tests at time ti and ni is the number of families still being observed at time ti, our estimator is
Results of applying this method are given in Tables 128 and 129 and Figure 126.
Adjustment for families without predictive tests
The data provided do not include families without any predictive tests. Ian Frayling has advised that the number of such families would be very low as the likelihood of identifying family members for testing is considered during genetic counselling, and, as a result, people without relatives would be less likely to be tested. Ian Frayling gave an estimate that 2% of probands, or fewer, would never identify relatives to be tested. To investigate the effect of this on our analysis, we added a family which would be observed throughout the experiment but would never lead to a predictive test. As there were originally 33 families, this meant that 1 out of 34 = 2.9% of probands would never identify relatives to be tested.
The results with the adjustment are given in Tables 130 and 131 and Figure 127. Figure 128 additionally shows a comparison plot of the estimator with and without the adjustment.
- Analysis of data from Ian Frayling - A systematic review and economic evaluation...Analysis of data from Ian Frayling - A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
- Full list of authors - Validation and development of models using clinical, bioc...Full list of authors - Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
- Protocol - Improving the economic value of photographic screening for optical co...Protocol - Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study
- Acknowledgements - Adalimumab, etanercept and ustekinumab for treating plaque ps...Acknowledgements - Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
- List of supplementary material - Strategies for older people living in care home...List of supplementary material - Strategies for older people living in care homes to prevent urinary tract infection: the StOP UTI realist synthesis
Your browsing activity is empty.
Activity recording is turned off.
See more...